structural heart disease

Echo IQ's EchoSolv running on a digital tablet

Sydney-based medtech Echo IQ brings AI heart screening platform to the US

By Adam Ang 12:02 am December 8, 2022

ASX-listed medical AI company Echo IQ has launched its cloud-based platform for screening structural heart disease in the United States. WHAT IT DOES The software platform called EchoSolv supports the identification of structural heart diseases, including guideline-defined aortic stenosis at present, automating this process using AI. It can also complete bulk assessments at a rate of up to 48,000...

With CardioCare already in its portfolio, egnite plans to develop more solutions that harness data science to improve patient outcomes and reduce healthcare costs.

Digital health company egnite launches with AI heart disease platform

By Mallory Hackett 02:00 pm February 10, 2021

A new digital healthcare company called egnite launched Wednesday with the goal of leveraging advanced technologies and analytics to improve health outcomes for structural heart-disease patients. Egnite originates from the CardioCare platform developed by Edwards Lifesciences, which is already deployed at over 50 hospitals and health systems across the country. The platform is designed to manage...